
Pfizer, J&J react to COVID-19 breakthrough infections
Fox News
Pfizer and J&J remain confident in their respective COVID-19 vaccines’ ability to prevent severe illness, hospitalization and death amid the spread of the highly transmissible delta variant, the companies told Fox News.
Pfizer declined to comment on the data released in the CDC’s Morbidity and Mortality Weekly Report, but told Fox News in an emailed statement, "The vaccine continues to be highly efficacious in preventing COVID-19, including variants and to date, no variant, including Delta, appears to have escaped the protection of the vaccine. Furthermore, two doses of BNT162b2 continue to show high efficacy from preventing severe disease and hospitalizations." Meanwhile, Johnson & Johnson backed the change in federal mask guidance and upheld the power of vaccination.More Related News